MRUS: Merus N.V. Stock

by  •  • Comments Off on MRUS: Merus N.V. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2,895.58
Enterprise Value ($M) 2,602.29
Book Value ($M) 647.93
Book Value / Share 9.38
Price / Book 4.47
NCAV ($M) 434.31
NCAV / Share 6.29
Price / NCAV 6.67

Profitability (mra)
Return on Invested Capital (ROIC) -0.33
Return on Assets (ROA) -0.43
Return on Equity (ROE) -0.62

Liquidity (mrq)
Quick Ratio 6.54
Current Ratio 6.54

Balance Sheet (mrq) ($M)
Current Assets 569.07
Assets 782.69
Liabilities 134.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 36.13
Operating Income -272.07
Net Income -215.33

Cash Flow Statement (mra) ($M)
Cash From Operations -185.84
Cash from Investing -220.22
Cash from Financing 494.01

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
9 days ago 13G Paradigm Biocapital Advisors LP 5.10
02-10 13G Wellington Management Group Llp 5.10 74.06
12-16 13G Commodore Capital Lp 5.50 11.94
11-14 13G/A Flynn James E 4.98 12.87
11-14 13G/A Samlyn Capital, Llc 3.80 -23.50
11-14 13G Rtw Investments, Lp 6.10
11-12 13G Fmr Llc 9.99
07-24 13G/A Incyte Corp 1.50 -74.83

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-04-07 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No. 1) (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 OR ☐ T
2025-02-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 58,474 296,667 19.71
2025-04-16 169,523 1,013,518 16.73
2025-04-15 104,396 455,407 22.92
2025-04-14 156,573 543,482 28.81

(click for more detail)

Similar Companies
MIRM – Mirum Pharmaceuticals, Inc. MNKD – MannKind Corporation
MNOV – MediciNova, Inc. MURA – Mural Oncology plc
NAII – Natural Alternatives International, Inc.


Financial data and stock pages provided by
Fintel.io